- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
The key to accelerating CT scans lies in planning
By immediately setting organ-based scan and recon ranges, FAST Planning utilizes a standardized workflow that not only saves time but also delivers more reproducible results.
The FAST CARE Technology focuses on two aspects: Fully Assisting Scanner Technologies (FAST) supports process optimization, and Combined Applications to Reduce Exposure (CARE) assists with dose reduction features.
Be FAST
FAST – our Fully Assisting Scanner Technologies – make time-consuming and complex procedures faster as well as far more intuitive. Your scans will be more reproducible and less prone to errors. One of FAST’s valuable features is FAST Planning.
FAST Planning
Immediate, organ-based setting of scan and recon ranges, leading to a faster, and more standardized workflow at the scanner. This optimized workflow can help to increase reproducibility.
Get your free 90-day trial licensehere
More information about the FAST CARE Technology can be found here
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
